A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.
Background Cardiovascular disease (CVD) is the leading cause of mortality worldwide, while depression is highly prevalent in this patient population and has long been regarded as an independent risk ...
Cash flow from operations of $336 million in Q4, up 59.8% vs. the prior year and $606 million for the full year, an increase of 20.9% vs. the prior year; free cash flow1 of $304 million in Q4, up 46.4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results